Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Rebif

Rebif is a medicine containing the active ingredient(s) interferon beta-1a. On this page you will find out more about Rebif, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: interferon beta-1a

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Rebif 12 million units (44 microgram)/0.5 mL injection solution, 3 x 0.5 mL syringes

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

REBIF is indicated for the treatment of: ? Patients with a single demyelinating event in the central nervous system with an active inflammatory process, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis. High risk can be inferred from cerebral MRI with 2 or more lesions suggestive of demyelination.,? Ambulatory patients with multiple sclerosis who have experienced two or more relapses within the last 2 years. REBIF therapy should not be initiated in secondary progressive MS patients who no longer experience relapses.¾

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Clear, colourless solution.
Dosage Form Injection, solution
Route of administration Subcutaneous
Medicine schedule
1 pre-filled syringe: Prescription Only Medicine, or Prescription Animal Remedy
12 pre-filled syringes: Prescription Only Medicine, or Prescription Animal Remedy
3 pre-filled syringes: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Syringe
Storage temperature Store at 2 to 8 degrees Celsius
Storage conditions Do not Freeze,Protect from Light,Refrigerate
Life time 2 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 4 results

Rebif | myVMC

Rebif treats multiple sclerosis. It contains interferon beta 1b which functions in a similar way to interferon from the immune system.

Read more on myVMC – Virtual Medical Centre website

Rebif prefilled syringe Solution for injection - myDr.com.au

Rebif prefilled syringe Solution for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Progressive Multiple Sclerosis | myVMC

This article is only available to professionals

Read more on myVMC – Virtual Medical Centre website

Multiple sclerosis (MS) - myDr.com.au

Multiple sclerosis (MS) is a chronic, often disabling disease that attacks the central nervous system; new immunomodifying treatments have recently become available.

Read more on myDr website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback